Virginia is set to become the first state to piggyback on new Medicare drug price negotiations to automatically cap payments for some of the country’s most expensive medications, sidestepping a lengthy review process that has stalled similar efforts in other states for years.
Lawmakers in at least three other states — Illinois, Louisiana and Rhode Island — are pursuing similar legislation, part of a growing trend to extend newly negotiated “maximum fair prices” for certain drugs under Medicare to consumers outside the federal program.
Already a subscriber? Sign in